期刊文献+

尿脱落细胞吖啶橙染色诊断膀胱移行细胞癌的意义 被引量:6

The significance of acridine orange stain in the diagnosis of transition cell carcinoma of bladder
下载PDF
导出
摘要 目的 探讨尿脱落细胞吖啶橙染色法(AO-F)阳性率与膀胱移行细胞癌之间的关系。方法 1993-01/2001-12因膀胱移行细胞癌住院手术患者60例,对肿瘤不同的分期、分级、大小、数目、部位来统计其AO-F的阳性率。结果 AO-F总阳性率为71.7%,浅表性膀胱癌和浸润性膀胱癌患者的AO-F阳性率分别为60.0%和88.0%;肿瘤分级Ⅱ级以下者AO-F阳性率41.7%,Ⅱ级或以上者AO-F91.7%;肿瘤直径≥2cm者AO-F阳性率为80.0%,<2cm者为63.3%.多发性和单发性膀胱癌AO-F阳性率分别为75.0%和70.0%;肿瘤累及膀胱三角区或膀胱颈部AO-F阳性率88.9%,未累及者68.6%。AO-F阳性者肿瘤复发率为48.8%,AO-F阴性患者52.9%。结论 AO-F阳性率与肿瘤的分期和分级有明显的相关性。肿瘤的大小、数目、部位及复发率和AO-F无明显相关性。 AIM To evaluate the significance of acridine orange stain (AO-F) in diagnosis of transitional cell carcinoma (TCC) of bladder. METHODS 60 patients with TCC of bladder were selected from 1993 to 2001.The positive rate of AO-F in different stages, grades, size, number, position of tumor were calculated. RESULTS The total positive rate of AO-F was 71.7%.The positive rate was 60.0% in Ta and T1 stage, 88.0% in invasive TCC, 41.7% in grade below Ⅱ 91.7% in grade Ⅱ or more than Ⅱ,80.0% in size of tumor more than 2 cm ,63.3% in size less than 2 cm,75.0% in multiple tumors,70.0% in single tumor,88.9% in tumor which involving trigone or neck of bladder,68.6% in tumor not in involving these regions respectively.The recurrence rate was 48.8% in patients with positive AO-F and 52.9% in patients with negative one. CONCLUSION A close association is observed between stage, grade of TCC and AO-F. There is no significant association between size, number, position of the tumor and A0-F,and between the recurrence of TCC and AO-F.
出处 《现代泌尿外科杂志》 CAS 2003年第3期142-144,共3页 Journal of Modern Urology
关键词 尿脱落细胞 吖啶橙染色 诊断 膀胱移行细胞癌 bladder neoplasm acridine orange cytology
  • 相关文献

参考文献2

二级参考文献10

  • 1王国民 缪廷杰 张元芳 熊汝成 周康 许迅辉.尿脱落细胞吖啶橙染色法诊断膀胱癌[J].临床泌尿外科杂志,1987,2(2):76-78.
  • 2Maulard -Durdux C, Housset M. Prognostic factors of infiltrating tumors of the bladder. Cancer Radiother, 1998, 2(Suppl 1):5~11.
  • 3Petrovich Z, Baert L, Boyd SD, Brady LW, et al. Management of carcinoma of the bladder. Am J Clin Oncol, 1998,21(3):217~22.
  • 4Petrovich Z, Jozsef G, Brady LW. Radiotherapy for carcinoma of the bladder: a review. Am J Clin Oncol , 2001, 24(1): 1~9.
  • 5Zein TA, Milad MF. Urine cytology in bladder tumor. Int Surg, 1991, 76(1) :52-54.
  • 6Andersen OP, Ladefoged C, Rohl HF, et al. Urine cytology as a supplement to cytoscopy and biopsy in the control of bladder tumor. Ugeskr Laeger, 1989,151(50) :3400~3401.
  • 7Misra V, Gupta SC, Tandon SP, et al. cytohisyological study of urinary bladder neoplasms. Indian J Pathol Microbiol, 2000,43(3) :303~309.
  • 8Priolo G, Gontero P, Martinasso G, et al. Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer. Clin Chim Acta, 2001, 305(1-2): 47~53.
  • 9Thomas L, Lyh H, Marberger M, et al. Multicenter trial of the quantitative BTA RAK assay in the detection of bladder cancer.Clin Chim, 1999,45(4) :472~477.
  • 10Maier U, Simak R, Neuhold N. The clionical value of urinary cytology: 12 years of experience with 615 patients. J Clin Pathol, 1995, 48(4):314~317.

共引文献4

同被引文献52

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部